“Blood glucose related adverse drug reaction of antitumor monoclonal antibodies: a retrospective analysis using Vigibase”, Braz. J. Pharm. Sci., vol. 59, p. e18893, Apr. 2023, doi: 10.1590/s2175-97902020000118893.